Tue Jan 3, 2023 – 5:11 pm EST
WASHINGTON, D.C. (LifeSiteNews) – The U.S. Food & Drug Administration (FDA) has announced it will amend the labeling for the Plan B emergency contraceptive pill to “clarify” that it is not an abortifacient, despite evidence that the drug can function by killing already-conceived embryos.
In an announcement made December 23, the FDA declared that Plan B “will not work if a person is already pregnant, meaning it will not affect an existing pregnancy. Plan B One-Step prevents pregnancy by acting on ovulation, which occurs well before implantation. Evidence does not support that the drug affects implantation or maintenance of a pregnancy after implantation, therefore it does not terminate a pregnancy.”
The FDA claim it was removing language acknowledging the possibility of preventing implantation because a review of “the current science supports a conclusion that Plan B One-Step works by inhibiting or delaying ovulation and the midcycle hormonal changes,” and that “there is no direct effect on postovulatory processes, such as fertilization or implantation.”
In fact, however, Plan B does have an abortifacient capacity, and whether it prevents fertilization or implantation depends on when it is taken relative to
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors